Last reviewed · How we verify

Qizhitongluo Capsule — Competitive Intelligence Brief

Qizhitongluo Capsule (Qizhitongluo Capsule) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Pain Management / Cardiovascular.

marketed Pain Management / Cardiovascular Small molecule Live · refreshed every 30 min

Target snapshot

Qizhitongluo Capsule (Qizhitongluo Capsule) — China Academy of Chinese Medical Sciences. Qizhitongluo Capsule is a traditional Chinese medicine formulation that promotes blood circulation and removes blood stasis to relieve pain and improve microcirculation.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Qizhitongluo Capsule TARGET Qizhitongluo Capsule China Academy of Chinese Medical Sciences marketed

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Qizhitongluo Capsule — Competitive Intelligence Brief. https://druglandscape.com/ci/qizhitongluo-capsule. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: